Literature DB >> 15649195

Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis.

K Preisz1, M Sárdy, A Horváth, S Kárpáti.   

Abstract

BACKGROUND: Recently, epidermal transglutaminase (TG) has been identified within the papillary IgA granules in dermatitis herpetiformis (DH). Although IgA type autoantibodies to tissue and epidermal TGs are characteristic serological markers for DH, these antibodies do not bind to normal papillary skin structures. AIMS: To test the possibility of IgA immune complex precipitation within the vessel walls as a first step in the pathogenesis of skin symptoms, we analysed immunoglobulin, complement, and epidermal TG deposition along the vascular system of DH skin.
METHODS: Punch biopsy specimen were taken from 116 DH patients' skin, and evaluated for the presence of vascular immune precipitates by direct immunofluorescence. Skin samples from 16 DH patients were also studied for tissue and epidermal TGs.
RESULTS: In 74 (64%) of the 116 DH skin studied, significant vascular staining accompanied the DH-specific granular IgA fluorescence (IgA and C3 in 39 patients; IgA alone in 18; IgA, C3 and IgM together in five; IgM alone in 12). In most cases (92%), the precipitates were detected in the small vessels of the papillary dermis; however, a subpapillary vascular fluorescence was also observed in a few patients (8%). Skin IgA colocalized with epidermal TG in the vessel walls and within the scattered papillary peri- and intervascular DH bodies. Tissue TG did not colocalize either with the immunoglobulins or with the complement precipitates of the dermis. Furthermore, we could not detect keratinocyte TG in the DH bodies nor in the vessel walls.
CONCLUSIONS: These findings support possible immune complex precipitation in the vessel walls of DH skin and further confirm the significance of epidermal but not tissue TG in the pathomechanism of skin symptoms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15649195     DOI: 10.1111/j.1468-3083.2004.01132.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  9 in total

Review 1.  [Dermatitis herpetiformis. An update of the pathogenesis].

Authors:  M Sárdy; J Tietze
Journal:  Hautarzt       Date:  2009-08       Impact factor: 0.751

Review 2.  Recent advances in dermatitis herpetiformis.

Authors:  Kimiko Nakajima
Journal:  Clin Dev Immunol       Date:  2012-07-02

Review 3.  Dermatitis herpetiformis: from the genetics to the development of skin lesions.

Authors:  Diletta Bonciani; Alice Verdelli; Veronica Bonciolini; Antonietta D'Errico; Emiliano Antiga; Paolo Fabbri; Marzia Caproni
Journal:  Clin Dev Immunol       Date:  2012-06-07

Review 4.  Complement system in dermatological diseases - fire under the skin.

Authors:  Jaana Panelius; Seppo Meri
Journal:  Front Med (Lausanne)       Date:  2015-01-29

Review 5.  Complement Activation in Inflammatory Skin Diseases.

Authors:  Jenny Giang; Marc A J Seelen; Martijn B A van Doorn; Robert Rissmann; Errol P Prens; Jeffrey Damman
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

Review 6.  Dermatitis Herpetiformis: Novel Perspectives.

Authors:  Emiliano Antiga; Roberto Maglie; Lavinia Quintarelli; Alice Verdelli; Diletta Bonciani; Veronica Bonciolini; Marzia Caproni
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

Review 7.  Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review.

Authors:  Gareth Edwards; Gilles F H Diercks; Marc A J Seelen; Barbara Horvath; Martijn B A van Doorn; Jeffrey Damman
Journal:  Front Immunol       Date:  2019-06-26       Impact factor: 7.561

Review 8.  Etiopathogenesis of dermatitis herpetiformis.

Authors:  Joanna Rybak-d'Obyrn; Waldemar Placek
Journal:  Postepy Dermatol Alergol       Date:  2022-02-28       Impact factor: 1.837

Review 9.  Review: dermatitis herpetiformis.

Authors:  Fernanda Berti Rocha Mendes; Adaucto Hissa-Elian; Marilda Aparecida Milanez Morgado de Abreu; Virgínica Scaff Gonçalves
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.